Background SOX9 mutations cause the skeletal malformation syndrome campomelic dysplasia in combination with XY sex reversal. Studies in mice indicate that SOX9 acts as a testis-inducing transcription factor downstream of SRY, triggering Sertoli cell and testis differentiation. An SRY-dependent testis-specific enhancer for Sox9 has been identified only in mice. A previous study has implicated copy number variations (CNVs) of a 78 kb region 517-595 kb upstream of SOX9 in the aetiology of both 46,XY and 46,XX disorders of sex development (DSD). We wanted to better define this region for both disorders.
INTRODUCTION
A decisive step in human sexual development, as in mammals in general, is the determination of the bipotential gonad to develop either into testes, if the chromosomal sex is 46,XY, or into ovaries, if the chromosomal sex is 46,XX. Testis determination in mammals depends on the action of the Y-chromosomal gene SRY, which activates the SOX9 gene. The essential role of SOX9 in testis formation is apparent from heterozygous SOX9 mutations that lead to campomelic dysplasia (CD; MIM 114290), a skeletal malformation syndrome with male-to-female sex reversal in about 70% of 46,XY individuals. 1 2 The observations that lack of gonadal Sox9 expression leads to the formation of ovaries in XY mice, 3 while ectopic gonadal SOX9/ Sox9 expression causes the formation of testes in XX humans and mice, 4 5 and thus in the absence of SRY/Sry, have established that SOX9/Sox9 is both necessary and sufficient for testis induction.
A hallmark discovery in the elucidation of the gene regulatory casacade involved in early testis development has been the identification of a testisspecific enhancer of mouse Sox9 (TES), located 13 kb upstream of the gene. 6 We have previously scrutinised the human TES-homologous sequence, 14 kb upstream of SOX9, for mutations in a cohort of 66 patients with SRY-positive (lacking SRY mutations) 46,XY disorder of sex development (DSD), but failed to uncover any mutation. 7 One likely interpretation of this result is that one or more testis-specific enhancers are located elsewhere in the extended regulatory domain of SOX9. 8 Likewise, breakpoints in CD translocation cases with XY sex reversal scatter from 50 kb to several 100 kb upstream of SOX9, 9 and thus do not sever the TES-homologous sequence from the gene. This fact also points to the existence of other testisspecific enhancers in humans.
Recently, several 46,XX DSD cases with large duplications/triplication upstream of SOX9, and two 46,XY DSD patients with large deletions upstream of SOX9 have been described. [10] [11] [12] [13] [14] Together, these copy number variations (CNVs) define a 78 kb region located 517-595 kb upstream of SOX9, termed RevSex, assumed to contain a gonad-specific enhancer(s), gain or loss of which results in activation or inactivation of gonadal SOX9 expression. 12 We now describe four SOX9 upstream deletion cases with SRY-positive 46,XY DSD and three SOX9 upstream duplication cases with SRY-negative 46,XX DSD. The four deletion cases define a new 32.5 kb interval, designated XYSR (for XY sex reversal region), which overlaps with previously described SOX9 upstream deletions, but not with the RevSex region. The three duplication cases, together with published SOX9 upstream duplications, define a 68 kb region, termed XX sex reversal region (XXSR), which is largely identical to the RevSex region. We propose that the XYSR and the XXSR harbour differently-acting gonad-specific regulatory elements: loss of enhancer(s) from the XYSR result in loss of testicular SOX9 expression and in XY sex reversal, while copy number gain of regulatory sequences from the XXSR lead to increased gonadal SOX9 expression and to XX sex reversal.
SUBJECTS AND METHODS Human subjects
The individuals of the SRY-positive 46,XY DSD patient cohort comprising 100 cases had clinically and endocrinologically confirmed or suspected diagnosis of isolated, non-syndromic partial or complete XY gonadal dysgenesis (Swyer syndrome); deletion or mutation of SRY had been excluded by PCR and DNA sequencing. The individuals of the SRY-negative 46,XX DSD patient cohort of 19 cases had clinically and endocrinologically confirmed or suspected diagnosis of testicular or ovotesticular DSD; absence of SRY had been diagnosed by PCR. Clinical details for the SRY-positive 46,XY DSD patients DSD1-DSD4 and the SRY-negative 46,XX DSD patients DSD5-DSD7 can be found in the online supplementary data.
Genomic copy number analysis
For the DSD1 case, multiple ligation-dependent probe amplification (MLPA) was initially performed, using the SALSA MLPA Kit P185 Intersex (MRC-Holland, Amsterdam, Netherlands), which includes amplicons 1499, 1008, 1007, 483 and 243 kb upstream of SOX9. Quantitative PCR was done as described 7 ; primer sequences are available on request. Microarray-based comparative genomic hybridisation was carried out as described in online supplementary data.
PCR and DNA sequence analysis
Standard PCR of the 46,XY DSD cohort DNA samples for the conserved non-coding elements CNE1-5 for subsequent DNA sequence analysis was performed using primers listed in online supplementary table S1; for CNE0, primers used were 5 0 -GGTGAAGGGGAATAAAACAGTTG-3 0 and 5 0 -TGGCAGA AACCCAATCATTTAG-3 0 ( product size 775 bp; chr. 17 coordinates 69 480 666-69 480 239, hg19). For the following longrange PCR protocols, the Phusion Hot Start II DNA Polymerase kit (Thermo Fisher Scientific, Schwerte, Germany) was used. For breakpoint-spanning PCR of DSD1, DSD2 and DSD4, cycling conditions used were 94°C for 10 min, and 40 cycles at 94°C (1 min), 57°C (1 min), and 72°C (1 min), with final amplification at 72°C (7 min). For efficient amplification of 10-13 kb fragments, cycling conditions used were 92°C for 2 min, 10 cycles at 92°C (10 sec), 61°C (30 s), and 68°C (9 min), followed by 20 cycles at 92°C (10 s), 60.5°C (30 s), and 68°C (18 min plus 10 s per cycle), with final amplification at 68°C (7 min). PCR products were sequenced either in-house on an Applied Biosystems 31 030×1 Genetic Analyzer, or by a commercial supplier (GATC, Konstanz, Germany).
Plasmids
Fragments F1-F17 and CNE1-CNE7 used for construction of reporter plasmids were amplified by PCR from genomic DNA (primers in online supplementary table S1) and cloned in front of the 529 bp mouse Sox9 minimal promoter driving a luciferase reporter gene in the context of vector pLuc4 (kind gift of Veronique Lefebvre). For F1-F17, the In Fusion cloning kit Plus (Clontech Laboratories Inc, Mountain View, California, USA) was used. Fragment F8 was additionally cloned in front of the ß-globin TATA box followed by a luciferase reporter gene and a polyA cassette. pCMV5-based expression plasmids contained open reading frames for human SRY (generated from genomic DNA with primers 5 0 -ATGCAATCATATGCTTCTGC-3 0 and 5 0 -CTACAGCTTTGTCCAGTGGC-3 0 ), human SF1/NR5A1 and GATA4 (both from AMS Biotechnology, Oxon, UK) or mouse Wt1(-KTS) (kind gift of Christoph Englert).
Cell culture, transient transfections, and luciferase assays TM-4 mouse Sertoli (kind gift of Christoph Englert), NT2/D1 human embryonal carcinoma (obtained from ATCC; ATCC-CRL-1973), neuro-2a mouse neuroblastoma, and human HEK293 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (10% FCS). For luciferase reporter gene assays, cells were seeded on 35 mm plates. TM-4 and HEK293 cells were transfected with polyethylenimine (PEI), NT2/D1 and neuro-2a cells with Superfect reagent (Qiagen) using 500 ng of luciferase reporter plasmids per plate. In co-transfections, 15 ng of pCMV5-based expression vector for each transcription factor were additionally added. Total amounts of expression vector were kept constant at 30 ng using empty pCMV5 in cases were only a single transcription factor plasmid was transfected. Cells were harvested 48 h post-transfection and luciferase activity was determined in the presence of luciferin substrate by detection of chemiluminescence. 15 
RESULTS
Two separate SOX9 upstream regions are involved in 46,XY and 46,XX DSD This study was triggered by MLPA analysis, using the SALSA MLPA Intersex kit, of an SRY-positive 46,XY DSD patient, DSD1, with heterozygous deletion of a single amplicon 483 kb upstream of SOX9. By subsequent quantitative PCR (qPCR), array comparative genomic hybridisation (CGH) and sequencing of a PCR-generated junction fragment, the deletion was shown to cover 236 kb, 403.3-639.6 kb upstream of the SOX9 transcription start site (TSS) (figure 1 and see online supplementary figures S1 and S2). The deletion was maternally inherited (figure 2).
Next, we screened the cohort of 66 cases of SRY-positive 46, XY DSD due to XY gonadal dysgenesis (XY GD) we had analysed for mutations in the TES-homologous region, 7 plus an additional 33 such cases, by qPCR. Initially, amplicons from the DSD1 deletion were used for screening. Finally, the entire cohort was screened with four amplicons from the evolutionarily most conserved regions CNE1-4 from within the 32.5 kb interval defined by the DSD1 and DSD2 deletion (figures 1 and 3). Three additional heterozygous SOX9 upstream deletion cases were thus identified. In the two affected sibs of the DSD2 family (figure 2), a maternally inherited 65 kb deletion was detected, fine-mapped by array CGH and breakpoint sequencing (see online supplementary figures S1 and S2). It extends from 607.1-672.5 kb upstream of the SOX9 TSS (figure 1). From a six-generation family with five members with proven XY GD, 16 one affected individual, IV-25 in the DSD3 pedigree (figure 2), was shown by array CGH to carry a deletion from 510-646 kb upstream of SOX9 (figure 1 and see online supplementary figure S1). By qPCR, the deletion was shown to be present in the affected 46,XY female VI-2 and absent in the 46,XX females V-26 and V-38. From the pedigree, the deletion is inferred to be transmitted through carrier females (grey central dots in the DSD3 pedigree; figure 2), none of whom was available for analysis. Finally, in a four-generation family, DSD4, with three diagnosed XY GD cases, 17 a large deletion was identified by qPCR in the two affected sisters III-10 and III-11 (figure 2) and characterised by array CGH and breakpoint sequencing for individual III-10 (see online supplementary figures S1 and S2). The deletion extends from 132.1-709.0 kb upstream of SOX9 (figure 1). As in the DSD3 pedigree, the deletion is inferred to be inherited from 46,XX carrier females. Thus, in all four pedigrees, the male-to-female sex reversal follows an autosomal dominant mode of inheritance affecting only 46,XY individuals.
The DSD1-DSD4 deletions overlap and result in a common deleted region of 32.5 kb, defined by the left, centromeric breakpoint of the DSD1 deletion at -639.6 kb and the right, telomeric breakpoint of the DSD2 deletion at -607.1 kb. This region, designated XYSR (for XY sex reversal region), does not overlap with the 78 kb RevSex region implicated in both 46,XY and 46,XX sex reversal (figure 1). 12 We also identified three SOX9 upstream duplications in a cohort of 19 cases of SRY-negative 46,XX testicular or ovotesticular DSD. Array CGH revealed a size of 143 kb, 516-659 kb upstream of SOX9, for DSD5, and of 444 kb, 259-703 kb upstream of SOX9, for DSD6 (figure 1 and see online supplementary figure S3). In both cases, fluorescence in situ hybridisation (FISH) analysis with a bacterial artificial chromosome (BAC) from the duplicated region revealed that the duplications are tandem duplications on chromosome 17q (see online supplementary figure S4). The DSD7 duplication could only be analysed by qPCR, giving a size of at least 480 kb, 264-744 kb upstream of SOX9 (minimum duplication size chr17:69 371 938-69 852 771; maximum duplication size chr17:69 370 916-69 855 932; hg19 coordinates) (figure 1). Whereas parental DNA samples were not available for DSD5 and only a sample from the mother of DSD7, who did not carry the duplication, the duplication was shown to be paternally inherited in the case of DSD6 (figure 2). The three duplications and the previously published SOX9 upstream duplication/triplication cases [10] [11] [12] [13] share a common duplicated region of 68 kb, 516-584 kb upstream of SOX9, defined by the centromeric duplication breakpoint from Xiao et al 13 and the telomeric breakpoint of the DSD5 duplication ( figure 1 and see online supplementary figure S3 ). This 68 kb interval, designated XXSR (for XX sex reversal region), is largely identical with the 78 kb RevSex region (figure 1). Color-intensive dashed bars represent deletions in isolated 46,XY DSD patients, 12 14 while grey dashed bars represent deletions in syndromic 46,XY DSD patients. [26] [27] [28] The borders of the DSD1 and DSD2 deletions define the common deleted region of 32.5 kb (XY sex reversal region (XYSR), red area). Black bars and a white bar represent duplications and a triplication, respectively, in patients with isolated 46,XX DSD. [10] [11] [12] [13] For DSD7, the minimum duplication size is shown. Faint grey solid bars represent duplications in brachydactyly-anonychia patients who lack 46,XX DSD. 35 The borders of the DSD5 duplication from this study and of the duplication reported in Xiao et al 13 delimit the common duplicated region of 68 kb (XX sex reversal region (XXSR), blue area). The deletions of all 46,XY DSD patients but the DSD2 patient cover also the entire 68 kb XXSR. This region is similar to the 78 kb RevSex region, implicated in both XX and XY sex reversal. 12 Relative coordinates refer to the SOX9 transcription start site (TSS; arrow at right). Absolute coordinates are according to the GRCh37/hg19 genome assembly.
Sanger sequencing of SRY, SOX9, WT1, SF1/NR5A1, DHH, MAP3K1, and CBX2, mutations in which are associated with 46, XY DSD, 18 did not uncover mutations in DSD1 to DSD4. Likewise, sequencing of WNT4 and RSPO1, implicated in cases of 46,XX DSD, 18 did not reveal mutations in DSD5 to DSD7.
The 65 kb DSD2 deletion is crucial for the definition of the right, telomeric border of the XYSR (figure 1). To check if, in addition to the 65 kb deletion, a small deletion below the resolution level of the array CGH might be present in the 78 kb RevSex region, 13 long-range PCR amplicons of around 7 kb Figure 3 The 32.5 kb XY sex reversal region (XYSR) and fragments used for analyses. The 32.5 kb XYSR 607.1-639.6 kb upstream of SOX9 is depicted as a long black bar at top. The positions of the seven fragments used for the generation of transgenic constructs and of fragments F1-F17 used in cell transfections are indicated; fragment F8 was also analysed in transgenic mice, indicated in red. Conservation of the region can be seen in the Mammal Cons panel, indicating the presence of eight conserved non-coding elements in the region, four most conserved elements, CNE1-4, and four less conserved elements, CNE0 and CNE5-7. Presence of interspersed repeats and of low complexity DNA sequences is displayed by black bars in the Repeat Masker panel at bottom. The figure was constructed using the UCSC Genome Browser. each were generated that covered the entire 78 kb region in an overlapping manner. All amplicons from the DSD2 patient and from a control were of identical size, excluding deletions larger than about 0.5 kb in DSD2. As small deletions affecting primer binding sites would lead to amplification of only the wildtype allele, qPCR was performed using amplicons inside or overlapping with the overlap region of the long range PCR amplicons. None of the amplification products showed deviation from the expected diploid dosage (data not shown). Thus, additional CNVs in the 78 kb region could be excluded in the DSD2 patient, at least down to the level of resolution of the applied analyses.
An sry-responsive subfragment from the XYSR with activity in sertoli cell lines
To narrow down the 32.5 kb XYSR even further, we searched for early testis-specific enhancer activity in transgenic mice. Three larger, overlapping fragments, UL1-UL3, which together cover the entire 32.5 kb region, four smaller fragments, CNE1 to CNE4, which span the four best-conserved sequences from the XYSR (figure 3), and fragment F8 (see below), were cloned in front of a minimal promoter and a lacZ reporter gene. Transgenic founders were expanded into lines before analysis or analysed through their direct offspring. Analysis was at E10.5, E11.5 and E12.5, the time window of Sry expression and the onset of Sox9 expression. 19 Apart from lacZ expression in the neural tube, due to cryptic elements present in the lacZ transgene, 20 and in various other tissues, none of the more than 300 embryos scrutinised showed lacZ expression in the male, or female, gonad (see online supplementary table S3). The single exception was an E10.5 female embryo transgenic for the central UL2 fragment which, in contrast to his littermates and all other UL2-transgenic embryos, had much stronger staining in various tissues including the gonad (not shown). This outlier result proved to be unreproducible in either sex.
We also analysed our entire cohort of SRY-positive 46,XY DSD cases for mutations in the conserved regions CNE0, CNE1, CNE3, CNE4, and CNE5 (CNE2 was not amenable to Sanger sequencing due to internal polyA stretches). Apart from common single nucleotide polymorphisms (SNPs) and one variant each in SRE0 and SRE1, which did not affect predicted transcription factor binding sites and for which inheritance could not be clarified due to lack of parental samples, no point mutations or small deletions/duplications were detected.
Finally, we performed transfections of reporter gene constructs under control of the minimal Sox9 promoter and additional XYSR fragments into various cell lines. For this, the 32.5 kb region was subdivided into 17 overlapping fragments, F1 to F17 (figure 3). Also, fragments spanning the conserved non-coding elements CNE1 to CNE7 were cloned in a similar manner. Resulting plasmids were transfected into the mouse Sertoli-like cell line TM-4 and into the human embryonal carcinoma cell line NT2/D1 which expresses several Sertoli markers including SRY and SOX9. 21 Transfections in the human kidney cell line HEK293 and the mouse neuroblastoma cell line neuro-2a served as controls as they should allow to distinguish fragments with general stimulatory activity from those with Sertoli cell-specific activity. Whereas none of the conserved elements CNE1-7 showed Sertoli cell-specific activity (not shown), of all 24 constructs tested, F8 showed the highest luciferase activities in both Sertoli-like cell lines (see online supplementary figure S5A, B) . In contrast, the same fragment had little influence on luciferase activity in both HEK293 and neuro-2a control cell lines (see online supplementary figure S5C, D) .
Even though F7 and F9 overlap with F8 ( figure 3 and online  supplementary figure S6) , their luciferase activities are weak in TM-4 and unremarkable in NT2/D1. Thus F8 appeared to be the best candidate for a testis-specific enhancer of the SOX9 gene.
Such an enhancer should be under control of SRY, but could possibly also be influenced in its activity by other transcription factors present in the early gonad and essential for gonadal differentiation, including SF1 (also known as NR5A1), WT1, and GATA4. [22] [23] [24] To test this assumption, a luciferase reporter containing F8 in front of the ß-globin TATA box was co-transfected in neuro-2a cells with expression plasmids for these factors. Of all factors tested, only SRY elicited a substantial 10-fold increase in luciferase activity. WT1 stimulated reporter activity twofold, whereas SF1 and GATA4 were completely ineffective ( figure 4A ). To address whether higher activation rates could be achieved by transcription factor combinations, neuro-2a cells were transfected with the F8 luciferase reporter and expression plasmids for SRY and one of the other factors. Strong synergism was observed for SRY and WT1 with a 120-fold induction, a 10-fold activation over the effect with SRY alone. In contrast, addition of GATA4 to SRY had no effect, whereas addition of SF1 to SRY showed an inhibitory effect ( figure 4B) . Together, the transfection data indicate that the 1.9 kb F8 is the only fragment from the XYSR with Sertoli cell-specific activity, likely due to the presence of an SRYand WT1-responsive enhancer element. In fact, F8 contains 
DISCUSSION
We describe here overlapping deletions upstream of SOX9 in four unrelated families, DSD1-DSD4, with members with SRY-positive 46,XY DSD and no signs of CD. As in the two previously published cases, 12 14 the deletion is always transmitted by unaffected 46,XX carrier mothers. This clarifies the mechanism underlying the male-to-female sex reversal in the DSD3 and DSD4 families after more than three decades. 16 17 The 577 kb deletion in the DSD4 family is so far the largest SOX9 upstream deletion in isolated XY sex reversal. As this deletion removes a significant fraction from the SOX9 regulatory domain and has one breakpoint only 132 kb from the gene, one might wonder if the three affected individuals have some of the symptoms found in CD, such as short stature. However, no skeletal phenotype is mentioned, and height was normal to increased. 17 Correspondingly, the DSD4 deletion does not remove the evolutionarily conserved SOM enhancer at -70 kb which regulates expression of mouse Sox9 in many somatic tissues including cartilage, but not in testis. 25 We also describe overlapping duplications 5 0 to SOX9 in three unrelated cases, DSD5-DSD7, who are SRY-negative 46,XX individuals with isolated female-to-male ovotesticular DSD. In DSD6, the duplication could be shown to be inherited from the unaffected 46,XY father, as in the other such cases. [10] [11] [12] [13] The 32.5 kb XYSR located 607.1-639.6 kb upstream of SOX9, defined by the overlapping deletions in the 46,XY DSD families DSD1 and DSD2, is also deleted in DSD3 and DSD4, in the two other deletion cases with isolated 46,XY DSD, 12 14 and in three large deletions in patients with XY DSD in combination with severe or mild forms of CD ( figure 1) . [26] [27] [28] The XYSR is also in accordance with SOX9 upstream translocation breakpoints in cases of CD with XY sex reversal. All but one of these breakpoints are within 500 kb from SOX9, severing the XYSR from the gene, whereas the TES region close to SOX9 remains unaffected (figure 5). The exception is a breakpoint at -789 kb in a complete XY sex reversal case with the acampomelic form of CD and a 46,X,t(Y;17)(q11.2;q24.3) translocation. As the Y chromosome breakpoint maps within the Yq heterochromatic region, silencing of SOX9 by spreading of heterochromatinisation is a likely explanation for the XY sex reversal, despite the retention of the XYSR. 9 Notably, in contrast to some patients with 46,XY DSD, no translocation breakpoints between the XXSR and SOX9 have been reported for 46,XX DSD individuals (figure 5).
Benko and co-authors previously described a 78 kb region located 517-595 kb from SOX9, termed RevSex, which they implicated in both 46,XY DSD and 46,XX DSD. Whereas the centromeric border of this region at -595 kb was defined by a duplication in a 46,XX DSD case, the telomeric border at -517 kb was defined by a deletion in a syndromic 46,XY DSD case. 12 With the DSD5 duplication case presented here and a recently reported duplication case, 13 the 68 kb XXSR located 516-584 kb upstream of SOX9 is now based solely on the breakpoints of 46,XX DSD duplication cases. Notably, the XYSR and XXSR do not overlap, but are separated by 23 kb ( figure 1) . Thus, the critical interval upstream of SOX9 implicated in the two opposing forms of DSD can now be assigned to two different regions, XYSR for 46,XY DSD and XXSR for 46,XX DSD. The mechanism by which deletions of the XYSR lead to XY sex reversal likely involves removal of one or more enhancers essential for activation of SOX9 in the early male gonad, resulting in failure of testis induction and thus in ovary development. As SRY acts upstream of SOX9, these enhancers are probably responsive to SRY, possibly in combination with other transcription factors such as SF1, as shown for the TES enhancer in mice. 6 We found that fragment F8 mediates Sertoli cell-specific activity in cell culture, responds to SRY and contains several SRY binding sites, one of which is conserved in mice (see online supplementary figure S6). In contrast to the situation at the TES enhancer, synergism was not observed between SRY and SF1 but between SRY and WT1, even though F8 contains predicted binding sites for both SF1 and WT1, which are not conserved in mice (see onlinesupplementary figure S6 ). So far, WT1 has been implicated in the direct regulation of SRY, 29 but not in that of SOX9. The fact that fragment F8 displayed activity only in Sertoli-like cells is likely due to the combinatorial presence of canonical and possibly non-canonical transcription factor binding sites for several gonad-specific transcription factors, which scatter over its entire 1877 bp and which act in concert.
Several mechanisms can be proposed by which duplications of the XXSR can cause XX sex reversal. Before onset of Sry expression, Sox9 is expressed at a low level in the cytoplasm of somatic cells of the bipotential gonad in both sexes, to become nuclear and upregulated by SRY at the onset of testis differentiation and downregulated in the XX gonad. 30 31 Therefore, molecular key players of early bipotential gonad development such as SF1, WT1, GATA4 and CBX2 must be capable to allow basal SOX9 expression. 18 A duplication adding a third copy could increase this basal expression level above the threshold needed for testis induction. Interestingly, a duplication of the entire SOX9 region 9 43 44 The 46,XX DSD translocation breakpoint is shown by a vertical line with a square. 36 TES and SOM refer to the human homologues of the murine testis and somatic enhancer, respectively. 6 25 The scale at bottom gives distances relative to SOX9. including its regulatory domain was able to trigger XX female-to-male sex reversal in human, deer and dog. 4 32 33 Benko and co-workers suggest the involvement of epigenetic packaging of the 78 kb RevSex region, which includes the XXSR, in the regulation of SOX9 expression. 12 In their scenario, the addition of a third copy causes local chromatin alteration, allowing this third copy to escape the repressive 'female' chromatin environment and to adopt a permissive 'male' chromatin state, resulting in activation of putative testis-specific enhancers within the RevSex/XXSR region, leading to upregulation of SOX9. In support of this, a recent study reported that the RevSex duplication in a 46,XX DSD individual was associated with a more open chromatin signature as also observed in male but not female controls. 34 However, as this study was performed on primary fibroblasts, it may not reflect the state of early gonadal Sertoli or granulosa cells.
The Benko model also provides an explanation why the brachydactyly-anonychia patients (faint grey solid bars in figure 1 ) 35 showed no XX sex reversal, because their large duplications might not have led to a derepressed chromatin state of the third copy of the RevSex/XXSR region. Two additional reports argue for the possible involvement of chromatin packaging in suppression of the XXSR in the wildtype 46,XX situation. One is the description of a 46,XX,t(12;17)(q14.3;q24.3) translocation patient with the breakpoint at about 776-811 kb upstream of SOX9, where the XX sex reversal is supposed to result from translocation of the SOX9 region to a region of active chromatin state on chromosome 12 ( figure 5) . 36 And the suggested model for the XX sex reversal in the Ods mouse mutant also involves chromatin states at the Sox9 locus. 37 In light of the chromatin model, the XYSR might bear sequences necessary for the initiation or establishment of a permissive 'male' chromatin state of the XXSR, possibly involving the action of SRY. In such a scenario, deletion of the XYSR in XY individuals would lead to a repressive 'female' chromatin state of the XXSR resulting in the absence of SOX9 expression.
Although we succeeded in identifying an XYSR subregion with Sertoli-specific transcriptional activity, we could not detect any testis-or gonad-specific activity in the 32.5 kb XYSR in transgenic mice. This negative outcome might be attributed to the fact that we tested human genomic fragments in a mouse genomic background. While we have previously been successful in this trans-species approach, resulting in the identification of several tissue-specific Sox9 enhancers, 38 species differences can result in differences in the interpretation of regulatory sequences by the transcriptional machinery. 39 40 That fragment F8, which showed activity in transfections into the mouse Sertoli-like TM4 cell line, scored negative in the early testis when tested as a transgene in vivo, may be explained by assuming that the in vivo lacZ reporter assay is less sensitive than the in vitro luciferase reporter assay. It is also possible that several enhancer elements necessary for testis-specific activation of SOX9 are distributed over the entire 32.5 kb XYSR and must act together. Mice transgenic for multiple copies of the F8 fragment or for BACs covering the whole XYSR could be used to test these hypotheses. If the outcome is negative, it would not necessarily exclude that testis enhancers reside within the XYSR. These enhancers might need to interact, for example by chromatin looping, with auxiliary testis enhancers outside the 32.5 kb region, perhaps located in the human TES-homologous region, which by itself did not drive testis expression in the context of human YAC (yeast artificial chromosome) transgenic constructs extending up to 350 kb 5 0 to SOX9. 41 In a 4C analysis, the RevSex region indeed showed long range chromatin interactions with the SOX9 promoter, but only in lymphoblasts and not in a Sertoli cell line. 42 In conclusion, our results point to the existence of two separate, far upstream SOX9 regulatory regions, XYSR and XXSR, which cause the two opposing forms of DSD in humans when deleted or duplicated, respectively. So far unexplained cases of isolated SRY-positive 46,XY DSD and SRY-negative 46,XX DSD might carry CNVs in these regions. Their identification could eventually lead to a further refinement of the critical intervals, thus aiding in the search for the still elusive regulatory elements residing in the XYSR and XXSR. Fragment F8 might be part of them.
